Pearl, a California-based dental AI company, has landed $58 million in Series B funding. London-based Left Lane Capital led the round, with participation from Smash Capital, Alpha Partners, and existing investors, Craft Ventures, which invested in Suger, and Neotribe Ventures. Notably, this round marks the largest investment ever in dental artificial intelligence.
How will it use the investment?
With this investment, Pearl will continue to advance innovation in technologies that enhance the health of dental patients around the world by expanding its line of dental AI products, broadening its regulatory and patent portfolio, and increasing global access to the transformative benefits of AI in dentistry.
“We have spent the past year evaluating this market and it is clear that Pearl stands above peers at the forefront of dental innovation,” said Vinny Pujji, Managing Partner at Left Lane Capital. “Pearl’s pioneering dental Al improves diagnostic accuracy and efficiency while transforming the provider-patient relationship. We’re confident in Pearl’s ability to continue setting new standards of care and are thrilled to support their next phase of growth.”
How was the idea born?
Pearl was founded by Ophir Tanz and Dr. Kyle Stanley in 2019 as a member of the NVIDIA Inception startup program to elevate dentistry’s patient care. As they grew up with dentist fathers, Ophir and Cambron Carter joined forces at GumGum, a digital media company, which Ophir founded in 2008. They spent 10 years applying AI technology to deliver digital advertising and sports sponsorship solutions. Later, they joined hands to establish Pearl to revolutionise dental practices worldwide.
What does the company do?
Its AI technology offers a seamless and less invasive approach to dental diagnostics. By accurately detecting disease and displaying clinical findings that are easy for patients to understand, the company’s FDA-cleared software enhances the efficiency, consistency, and precision of radiologic exams, while also facilitating patient education and engagement in their dental health.
Pearl will also enable dental professionals to continually raise the standard of care with more transparent, accurate, and objective diagnoses, more effective individualised care, and deeper patient trust in dentistry.
Pearl’s software platform, available in the cloud as a service, enables dentists to run real-time screening of X-rays. Dentists can then review the AI findings and share them with patients to facilitate informed dentist-patient discussions about diagnosis and treatment planning. Being the first-ever FDA clearance for AI software, it can spot not just tooth decay but many other dental issues, like cracked crowns and root abscesses requiring a root canal.
Other products from Pearl
The company’s products include its Practice Intelligence, which enables dental practices to run AI on patient data to discover missed diagnoses and treatment opportunities. Pearl Protect can help screen for dental insurance fraud, waste, and abuse, while Claims Review offers automated claims examination.
What do we think about Pearl?
Pearl is set to revolutionise dentistry with its AI-driven diagnostic tools, enhancing accuracy, efficiency, and patient engagement. By providing clear, precise diagnostics and facilitating transparent dentist-patient communication, Pearl’s technology improves patient trust and care standards.
Its FDA-cleared software, capable of detecting a range of dental issues, positions the company as a leader in the field. As dental practices increasingly adopt AI, Pearl’s innovations will play a pivotal role in transforming dental care globally.
